| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $516.0M | +4.5% |
| Cost of Revenue | $317.2M | +1.4% |
| Gross Profit | $198.8M | +10.0% |
| R&D Expense | $398K | -4.8% |
| SG&A Expense | $125.0M | +0.6% |
| Operating Income | $73.8M | +30.7% |
| Pre-tax Income | $70.8M | +22.2% |
| Income Tax | $14.8M | +31.4% |
| Net Income | $56.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $164.7M | +24.2% |
| Accounts Receivable | $63.5M | +26.7% |
| Inventory | $83.6M | +64.7% |
| Current Assets | $341.3M | +29.8% |
| Total Assets | $362.4M | +26.8% |
| Current Liabilities | $103.3M | +25.0% |
| Total Liabilities | $103.6M | +24.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $42.9M | -60.0% |
| Capital Expenditures | $974K | +62.6% |
| Investing Cash Flow | -$974K | -64.0% |
| Financing Cash Flow | -$8.3M | -231.9% |
| Free Cash Flow | $41.9M | -60.7% |
| +20.0% |
| EPS (Basic) | $0.99 | +19.3% |
| EPS (Diluted) | $0.94 | +19.0% |
| Stockholders' Equity |
| $258.8M |
| +27.9% |